Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Yolanda M Lenzy , MD

Dermatology • Chicopee, MA

Active NPI 1992831309 Individual Practitioner Female Practitioner Accepts Medicare assignment
Practice location in NPPES

1176 Memorial Dr
Chicopee, MA 010203958

Call 4133313676 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

1176 Memorial Dr

Chicopee, MA 010203958

Telephone 4133313676
Fax 4133314489
Organization at the Same NPPES Address or Phone
Fairview Pediatrics Facility NPI 1700855053

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Lenzy Dermatology Pc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

University Of Maryland School Of Medicine

Graduation Year

2004

Medicare patients

433 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $73,784 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $50,047 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

2,766 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$2,244,809 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $1,930.10 across 80 records.

By nature of payment

  • Food and Beverage: $1,830.11 across 79 records.
  • Education: $99.99 across 1 record.

Reporting-company totals (3 largest of 19)

  • ABBVIE INC.: $253.82 across 14 records.
  • Janssen Pharmaceuticals, Inc: $248.84 across 6 records.
  • Sanofi and Genzyme US Companies: $215.86 across 6 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

22 years (graduated 2004)

CMS Doctors and Clinicians data list 2004 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2007

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Lenzy has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Lenzy as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Chicopee and Massachusetts

Billing and prescribing volume is not a quality rating.

Medicare Part B services

Fewer Medicare Part B services than 75% of clinicians listed under Dermatology in Massachusetts (2024, 413 clinicians with data). Median for this group: 1,812. Middle half: 854 to 3,586.

Too few clinicians listed under Dermatology in Chicopee have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A lower Medicare-allowed amount than 65% of clinicians listed under Dermatology in Massachusetts (2024, 413 clinicians with data). Median for this group: $124,157. Middle half: $61,263 to $257,074.

Too few clinicians listed under Dermatology in Chicopee have Medicare Part B data for 2024 to compare.

Paid by Medicare

A lower Medicare payment amount than 65% of clinicians listed under Dermatology in Massachusetts (2024, 413 clinicians with data). Median for this group: $87,130. Middle half: $43,041 to $183,499.

Too few clinicians listed under Dermatology in Chicopee have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Dermatology in Massachusetts (2024, 464 clinicians with data). Median for this group: 431. Middle half: 156 to 822.

Too few clinicians listed under Dermatology in Chicopee have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Dermatology in Massachusetts (2024, 464 clinicians with data). Median for this group: $90,298. Middle half: $5,857 to $358,275.

Too few clinicians listed under Dermatology in Chicopee have Medicare Part D data for 2024 to compare.

1 active clinicians are listed under Dermatology with a practice address in Chicopee, MA (633 in Massachusetts).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 80 records totaling $1,930.10.

Manufacturer Payment Nature Product Type Amount ($)
Janssen Pharmaceuticals, Inc
Education
In-kind items and services
TREMFYA General $99.99
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $42.40
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $37.79
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $37.46
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $35.46
Amgen Inc.
Food and Beverage
In-kind items and services
OTEZLA General $34.85
Amgen Inc.
Food and Beverage
In-kind items and services
OTEZLA General $34.79
Amgen Inc.
Food and Beverage
In-kind items and services
OTEZLA General $34.37
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $34.16
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $33.59
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $33.29
Amgen Inc.
Food and Beverage
In-kind items and services
OTEZLA General $33.15
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
SPEVIGO General $32.12
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $31.65
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $31.42
Botanix SB Inc
Food and Beverage
In-kind items and services
SOFDRA General $31.02
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $30.88
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $30.24
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $29.89
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $29.16
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $28.51
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $28.27
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $28.23
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $28.13
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
ILUMYA General $28.04

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
392 334 $186.57 $91.60
17110 Destruction of skin growth, 1-14 growths
184 161 $238.11 $116.32
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
64 57 $262.65 $125.08
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
33 33 $227.76 $110.93
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
27 27 $116.62 $57.48
17000 Destruction of precancer skin growth, 1 growth
17 15 $140.71 $49.07
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
16 16 $148.69 $71.01
11102 Biopsy of related skin growth, first growth
13 12 $209.10 $98.91

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Minoxidil Minoxidil 277 19,807 $3,734.14 88
Ketoconazole Ketoconazole 246 7,357 $4,855.50 85
Betamethasone Dipropionate Betamethasone Dipropionate 244 7,216 $10,164.25 90
Fluocinonide Fluocinonide 159 4,561 $4,313.64 74
Doxycycline Monohydrate Doxycycline Monohydrate 87 2,690 $1,489.20 19
Triamcinolone Acetonide Triamcinolone Acetonide 82 2,509 $1,182.10 51
Hydrocortisone Hydrocortisone 77 1,688 $550.27 38
Clobetasol Propionate Clobetasol Propionate 69 2,394 $3,834.19 37
Doxycycline Hyclate Doxycycline Hyclate 64 2,460 $946.90 25
Otezla Apremilast 63 1,890 $301,424.44 —
Metronidazole Metronidazole 62 2,020 $2,801.44 19
Hydroxychloroquine Sulfate Hydroxychloroquine Sulfate 52 2,280 $1,937.10 11
Nystatin Nystatin 49 1,385 $879.09 20
Finasteride Finasteride 45 3,690 $562.81 15
Tretinoin Tretinoin 45 1,520 $2,667.92 16
Cosentyx Sensoready (2 Pens) Secukinumab 45 1,260 $321,234.30 —
Econazole Nitrate Econazole Nitrate 44 1,199 $1,398.60 20
Dupixent Pen Dupilumab 42 1,204 $167,396.44 —
Clindamycin Phosphate Clindamycin Phosphate 41 1,200 $1,119.82 20
Spironolactone Spironolactone 38 2,130 $763.07 —
Rinvoq Upadacitinib 24 720 $151,906.97 —
Dupixent Syringe Dupilumab 24 672 $137,325.96 —
Tremfya Guselkumab 22 1,204 $297,665.72 —
Skyrizi Pen Risankizumab-Rzaa 21 1,596 $432,004.39 —
Ciclopirox Ciclopirox 20 525 $727.64 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES MA 243134

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Massachusetts Board of Registration in Medicine.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
110092261A (MA)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20101013000015

Enrollment State Jurisdiction

MA

PECOS Control ID

8820280548

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Lenzy Dermatology Pc

1176 Memorial Dr, Chicopee, MA 010203958

Phone: 4133313676

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

2 listed
Ryan Mogadam

Physician Assistant - Medical

NPI 1558964445
NPI 1285608687

Doctor of Optometry

Career & Practice History

NPI enumerated February 27, 2007.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1992831309
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: February 27, 2007
Last Update: January 20, 2015
Sole Proprietor: No

Mailing Address

1176 Memorial Dr

Chicopee, MA 010203958

Phone: 4133313676

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.